Consolidated Balance Sheets - USD ($)	Dec. 31, 2018	Dec. 31, 2017
Current assets:
Cash and cash equivalents	$ 33,284	$ 84,902
Advance payment on research contract	48,912	48,912
Prepaid expenses, including current portion of long-term prepaid insurance of $14,945 at December 31, 2018 and 2017	38,880	42,897
Total current assets	121,076	176,711
Long-term prepaid insurance, net of current portion of $14,945 at December 31, 2018 and 2017	3,114	18,059
Total assets	124,190	194,770
Current liabilities:
Accounts payable and accrued expenses, including $400,229 and $228,939 payable to related parties at December 31, 2018 and 2017, respectively	3,303,120	2,922,013
Accrued compensation and related expenses	1,304,434	479,300
Convertible notes payable, currently due and payable on demand, including accrued interest of $62,635 and $98,646 at December 31, 2018 and 2017, respectively, (of which $38,292, including accrued interest of $13,292, was deemed to be in default at December 31, 2018) (Note 4)	239,666	374,646
Note payable to SY Corporation, including accrued interest of $315,307 and $267,335 at December 31, 2018 and 2017, respectively (payment obligation currently in default - Note 4)	744,441	583,827
Notes payable to officers, including accrued interest of $51,677 and $26,538 at December 31, 2018 and 2017, respectively (Note 4)	256,877	181,738
Other short-term notes payable	8,907	8,630
Total current liabilities	5,857,445	4,550,154
Commitments and contingencies (Note 9)
Stockholders' deficiency: (Note 6)
Series B convertible preferred stock, $0.001 par value; $0.6667 per share liquidation preference; aggregate liquidation preference $25,001; shares authorized: 37,500; shares issued and outstanding: 37,500; common shares issuable upon conversion at 0.00030 common shares per Series B share: 11	21,703	21,703
Common stock, $0.001 par value; shares authorized: 65,000,000; shares issued and outstanding: 3,872,076 and 3,065,261 at December 31, 2018 and 2017, respectively	3,872	3,065
Additional paid-in capital	158,635,222	157,422,110
Accumulated deficit	(164,394,052)	(161,802,262)
Total stockholders' deficiency	(5,733,255)	(4,355,384)
Total liabilities and stockholders' deficiency	$ 124,190	$ 194,770